GlassScriptPhysician profile
Joseph Casaly
NPI 1750381125
$94,686.01
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55K · 2020: $29K · 2021: $11K · 2022: $301.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $23,919.88 | 2019-2021 | |
| Amgen INC. | $23,086.23 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $22,207.31 | 2019-2020 | |
| Allergan, INC. | $14,034.35 | 2019-2021 | |
| Abbvie INC. | $6,111.07 | 2021-2022 | |
| Promius Pharma LLC | $4,963.97 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $61.92 | 2022 | |
| Novartis Pharmaceuticals Corporation | $57.85 | 2019 | |
| Lundbeck LLC | $55.70 | 2022 | |
| Assertio Therapeutics, INC. | $26.58 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $25.91 | 2021 | |
| Supernus Pharmaceuticals, INC. | $24.54 | 2019 | |
| Bausch Health US, LLC | $23.90 | 2019 | |
| Zyla Life Sciences, INC. | $15.75 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.17 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $15.11 | 2019 | |
| Merz North America, INC. | $14.71 | 2019 | |
| Horizon Therapeutics Plc | $13.06 | 2019 | |
| Merck Sharp & Dohme LLC | $13.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Casaly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.